Results 171 to 180 of about 10,597 (237)
Some of the next articles are maybe not open access.
Epsilon-Aminocaproic Acid for Synovectomy in Haemophilic Patients
Acta Haematologica, 1972The study of coagulation and fibrinolysis in synovectomised haemophilic patients, treated by a new haemostatic combined therapy, is reported. This treatment is based on a combination of replacement therapy (fresh frozen plasma and/or cryoprecipitates) and e-aminocaproic acid; the replacement therapy is continued for only 6 days, beginning on the day of
E, Storti +5 more
openaire +2 more sources
Myoglobinuria following epsilon-aminocaproic acid (EACA) therapy
Journal of Neurosurgery, 1980✓ Myoglobinuria developed in a patient with subarachnoid hemorrhage treated with a course of 1.43 kg of epsilon-aminocaproic acid (EACA) given over 41 days. Review of eight other cases with a variety of medical disorders shows that this effect occurs after at least 4 weeks of taking doses of a minimum of 24 gm EACA per day.
openaire +2 more sources
Epsilon‐aminocaproic acid myopathy
Australian and New Zealand Journal of Medicine, 1990J. RANDALL, K. TAYLOR
openaire +1 more source
Epsilon-Aminocaproic Acid Myopathy
European Neurology, 1982J.A.L. Vanneste, G.K. van Wijngaarden
openaire +1 more source
Diuretic Activity of Epsilon-Aminocaproic Acid
Pharmacology, 1968J, Garrett +2 more
openaire +2 more sources
Contact dermatitis from epsilon‐aminocaproic acid
Contact Dermatitis, 1993M, Tanaka, H, Niizeki, S, Miyakawa
openaire +2 more sources
Journal of Bone and Joint Surgery. American volume, 2017
C. K. Boese, Leslie Centeno, R. Walters
semanticscholar +1 more source
C. K. Boese, Leslie Centeno, R. Walters
semanticscholar +1 more source